International developed-market equities remain a focal point for many investors right now, especially as U.S. valuations look stretched and Europe and Japan offer more attractive relative discounts. The EFA and IDEV ETFs both come from iShares and provide broad exposure to developed markets outside the United States. They are not direct strategy competitors but differ mainly in scope: EFA serves as the established benchmark for Europe, Australasia, and the Far East, while IDEV offers a newer, lower-cost, and more complete version of similar exposure. I checked their relative characteristics using Tickeron’s AI tools to get a clearer picture of how the holdings line up.
The iShares MSCI EAFE ETF (EFA) aims to track the MSCI EAFE Index, a free-float-adjusted, market-capitalization-weighted benchmark focused on large- and mid-cap equities in developed markets outside the U.S. and Canada. It is passively managed and physically replicated, holding roughly 700 securities across 21 developed countries. The largest country allocations sit in Japan, the United Kingdom, and Switzerland.
Top holdings feature European multinationals such as ASML, AstraZeneca, Novartis, Roche, Shell, HSBC, Nestlé, Siemens, SAP, and Toyota Motor. Sector weights lean toward Financials (roughly 24–25%), Industrials (about 19%), Information Technology (around 11%), and Health Care (about 10%). The fund carries a net expense ratio of 0.32% and benefits from strong liquidity and a long track record.
The iShares Core MSCI International Developed Markets ETF (IDEV) tracks the MSCI World ex USA Investable Market Index, which covers large-, mid-, and small-cap developed-market equities outside the U.S. Importantly, it includes Canada and reaches further into small caps, unlike EFA.
The fund holds roughly 2,200–2,300 securities, with major country exposures in the Eurozone, Japan, the United Kingdom, and Canada. Top holdings include ASML, AstraZeneca, Novartis, Roche, HSBC, Shell, Nestlé, Royal Bank of Canada, Siemens, and Toyota Motor. Sector allocations are broadly similar but slightly more balanced, led by Financials (about 24%), Industrials (about 19%), Health Care (around 9%), and Information Technology (about 9%). Its standout feature is the net expense ratio of just 0.04%.
Both ETFs operate in the same environment, where international developed markets have gained from a weaker dollar, reasonable valuations, and solid shareholder-return programs in large European and Japanese companies. The significant Financials weighting in each makes them sensitive to interest-rate moves, while Industrials and Materials exposure ties them to global trade and capital-spending cycles. Japan continues to be an important variable, supported by governance reforms and a weak yen for export-oriented firms. Risks include a possible global slowdown, currency swings, geopolitical issues in Europe, and concentration in banks and cyclical sectors. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over recent weeks and months the two funds have generally moved together because they share a core of large developed-market holdings. Still, their positioning creates meaningful differences. IDEV’s inclusion of Canada and small caps brings exposure to Canadian financials and energy-linked names that EFA omits. EFA, in turn, carries a slightly heavier tilt toward its largest European positions and shows marginally higher single-name concentration. In recent cycles both have followed the broader shift toward value-oriented international equities, yet IDEV’s lower cost and wider reach have allowed it to compound the underlying exposure more efficiently.
Based on the structural factors outlined above, Tickeron’s AI would likely favor IDEV in this comparison. The fund delivers materially lower costs (0.04% versus 0.32%), broader diversification across roughly three times as many holdings, and more complete developed-market coverage that includes Canada and small caps. These traits generally lead to better risk dispersion and a higher likelihood of efficient long-term compounding. While EFA keeps an advantage in liquidity and familiarity, IDEV’s cost efficiency, diversification profile, and consistent exposure make it the stronger structural option for broad international developed-market positioning.
In my own analysis, I frequently rely on Tickeron’s AI Screener to compare ETF characteristics side by side. It lets me quickly filter by holdings overlap, expense ratios, and sector exposures, which helps confirm that the cost and diversification edge sits with IDEV while still showing where EFA’s liquidity profile may matter for certain strategies. This kind of data-driven check keeps the decision process grounded in observable metrics rather than assumptions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Moving Average Convergence Divergence (MACD) for EFA turned positive on October 15, 2026. Looking at past instances where EFA's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EFA as a result. In 64 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFA advanced for three days, in 260 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 60 cases where EFA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
EFA moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
EFA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EFA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows